评估前列腺癌患者女性伴侣性健康调查问卷的开发与验证
本研究通过文献回顾、两项定性研究和专家共识开发问卷,经认知访谈优化后,在200名美国前列腺癌患者女性伴侣中验证。最终27条目问卷经探索性因子分析消除8项,揭示7个关键因子,总体量表内部一致性(序数α 0.94)和重测信度(0.89)良好,形成SCIPPP-F问卷。
要点
- 开发并验证了首个评估前列腺癌患者女性伴侣性健康与生活质量的问卷SCIPPP-F。
- 问卷经探索性因子分析得到7个因子,总体内部一致性序数α为0.94,重测信度为0.89。
- 作者指出仍需开展额外工作以评估男性及非二元性别伴侣的性健康与生活质量。
核心结论
- 开发了新的测量工具SCIPPP-F,并在美国多样化女性伴侣样本中验证其有效性。
研究设计与样本
- 通过文献回顾、两项定性研究和专家共识过程开发评估性健康的问题。
- 候选条目经认知访谈测试并迭代优化问卷。
- 最终问卷在200名女性伴侣中开展验证研究。
- 采用探索性因子分析,随后分析内部效度、重测信度以及聚合效度和区分效度。
主要发现
- 初始开发32个条目,经认知访谈优化后形成27条目问卷。
- 探索性因子分析消除8个条目,揭示7个关键因子:痛苦/满意度、伴侣连接丧失、主动沟通、沟通不适、对性咨询的沮丧、性行为方式扩展、非插入式性活动。
- 总体量表显示较强的内部一致性(序数α 0.94)和重测信度(0.89)。
局限性
- 作者指出仍需开展额外工作以评估男性及非二元性别伴侣的性健康与生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prostate cancer (PCa) diagnosis and treatment can have a significant negative impact on sexual health, affecting patients and their partners; however, the impact on partners is insufficiently addressed in current practice. OBJECTIVE: We describe the development and validation of an instrument to measure sexual health in female partners of patients with PCa. DESIGN, SETTING, AND PARTICIPANTS: Questions assessing sexual health were developed through a literature review, two qualitative studies, and an expert consensus process. Candidate survey items were tested through cognitive interviews and used to iteratively refine the questionnaire. INTERVENTION: The final questionnaire was tested in a validation study among 200 female partners. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We performed an exploratory factor analysis, followed by an analysis for internal validity, test-retest reliability, and convergent and discriminant validity. RESULTS AND LIMITATIONS: An initial set of 32 items was developed and refined through cognitive interviews. The resulting 27-item questionnaire was tested among 200 female partners of patients with PCa from across the USA. The exploratory factor analysis eliminated eight items and revealed seven key factors: (1) distress/satisfaction, (2) loss of connection as a couple, (3) active communication, (4) discomfort with communication, (5) frustration with sexual counseling, (6) expansion of sexual repertoire, and (7) nonpenetrative sexual activity. The overall scale demonstrated strong internal consistency (ordinal alpha 0.94) and test-retest reliability (0.89). Strengths of the study include development and evaluation of the first questionnaire to evaluate sexual quality of life among female partners of patients with PCa. However, additional work is needed to assess sexual health and quality of life among male and nonbinary partners. CONCLUSIONS: We developed a new instrument, the Sexual Concerns In Partners of Patients with Prostate cancer (SCIPPP-F), and found it to be valid in a diverse sample of female partners across the USA. PATIENT SUMMARY: Our new instrument can be used to characterize sexual health among female partners of patients with prostate cancer.
引用
- Loeb S, Gupta N, Wittmann D, et al. Development and Validation of a Survey to Assess Sexual Health in Female Partners of Patients with Prostate Cancer. Eur Urol Oncol. 2024. PMID: 38762369. doi:10.1016/j.euo.2024.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。